News Quantified


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

Atai Life Sciences (ATAI): Assessing an Expensive-Looking Valuation After a Strong Share Price Run [Yahoo! Finance]

AtaiBeckley Added to the Nasdaq Biotechnology Index (NBI) [Yahoo! Finance]

AtaiBeckley Added to the Nasdaq Biotechnology Index (NBI)

Atai Life Sciences N.V. (ATAI) Secures Patent for Social Anxiety Disorder Formulation [Yahoo! Finance]

AtaiBeckley Announces New U.S. Patent Granted for EMP-01, Strengthening Intellectual Property Portfolio

11/12/2025

07:00 am

atai

1.9%

MISS

8/14/2025

07:00 am

atai

-0.5%

MISS

Form 8-K Atai Beckley N.V. For: Dec 05

Form 424B7 Atai Beckley N.V.

Form 4 Atai Beckley N.V. For: Nov 25 Filed by: Feilding-Mellen Cosmo

Form 10-Q Atai Beckley N.V. For: Sep 30

Form 8-K Atai Beckley N.V. For: Nov 12

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}